Academic · Private company
The University of Texas at Arlington
Track this companyFree. Adds The University of Texas at Arlington to your Dealase workspace and tells you when its record changes.
Clinical trials2510 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials25
- Reducing Cardiovascular Risks: The Role of Alcohol UseNA · RECRUITING · started Oct 1, 2026ClinicalTrials.gov NCT07783061 · fetched Nov 12, 2026
- Virtual Reality Lethal Means Safety TrainingNA · COMPLETED · started Mar 4, 2026ClinicalTrials.gov NCT07219355 · fetched Nov 12, 2026
- Using Near-Infrared Light to Better Understand Peripheral Artery DiseaseRECRUITING · started Nov 1, 2025ClinicalTrials.gov NCT07313410 · fetched Nov 12, 2026
- Asthma Intervention With Residential Ventilation and Air Cleaner (AIRVAC) StudyNA · RECRUITING · started Oct 10, 2025ClinicalTrials.gov NCT07196436 · fetched Nov 12, 2026
- Arlington Aging StudyRECRUITING · started Sep 1, 2024ClinicalTrials.gov NCT06857877 · fetched Nov 12, 2026
- Brain Vascular and Neurocognitive HealthNA · COMPLETED · started Apr 16, 2024ClinicalTrials.gov NCT06497413 · fetched Nov 12, 2026
- Black Women's Life Experience On Cardiovascular Health Via Ongoing MonitoringACTIVE_NOT_RECRUITING · started Mar 4, 2024ClinicalTrials.gov NCT06150989 · fetched Nov 12, 2026
- The Acute Effect of and Energy Drink vs. Water Consumption on MAP, HR, and Energy MetabolismNA · COMPLETED · started Jan 1, 2024ClinicalTrials.gov NCT06330649 · fetched Nov 12, 2026
- The Impact of Goode Health Beverage on Markers of Physiological and Neurocognitive HealthNA · COMPLETED · started Oct 1, 2023ClinicalTrials.gov NCT06245382 · fetched Nov 12, 2026
- The Impact of KETO5 XOGenius Beverage on Markers of Physiological and Neurocognitive HealthNA · COMPLETED · started Aug 1, 2023ClinicalTrials.gov NCT06318390 · fetched Nov 12, 2026
- Partnership in Resilience for Medication Safety (PROMIS)NA · COMPLETED · started Jun 26, 2023ClinicalTrials.gov NCT05880368 · fetched Nov 12, 2026
- Know and Own Your Movement-related Metrics Via Wearable DevicesNA · COMPLETED · started Mar 29, 2023ClinicalTrials.gov NCT05490641 · fetched Nov 12, 2026
- Reducing Blood Pressure in Mid-life Adult Binge DrinkersNA · RECRUITING · started Nov 21, 2022ClinicalTrials.gov NCT05522075 · fetched Nov 12, 2026
- Exploring Virtual Reality Adventure Training ExergamingNA · RECRUITING · started Sep 7, 2022ClinicalTrials.gov NCT05563805 · fetched Nov 12, 2026
- Peanuts and Neurocognitive / Cardiovascular Health in Black IndividualsNA · COMPLETED · started Sep 1, 2022ClinicalTrials.gov NCT06318377 · fetched Nov 12, 2026
- Effects of Exercise and Virtual Reality on DepressionNA · RECRUITING · started May 17, 2022ClinicalTrials.gov NCT05973461 · fetched Nov 12, 2026
- Virtual Reality-Infused Treadmill Training on Aging-Related OutcomesNA · RECRUITING · started May 10, 2022ClinicalTrials.gov NCT06727942 · fetched Nov 12, 2026
- Effect of Waterpipe Size on Smoking Behavior and ExposuresNA · COMPLETED · started Apr 22, 2022ClinicalTrials.gov NCT05705375 · fetched Nov 12, 2026
- Intergenerational Reminiscence and Digital StorytellingNA · COMPLETED · started Apr 15, 2021ClinicalTrials.gov NCT05984732 · fetched Nov 12, 2026
- The Senior Companion Program PlusNA · COMPLETED · started May 16, 2019ClinicalTrials.gov NCT03602391 · fetched Nov 12, 2026
- Local Antioxidant Therapy Vasoconstriction Effects in Different RacesPHASE1 · COMPLETED · started Oct 15, 2018ClinicalTrials.gov NCT03684213 · fetched Nov 12, 2026
- The Effect of Endothelin and L-Arginine on Racial Differences in VasoconstrictionPHASE1 · COMPLETED · started Oct 1, 2018ClinicalTrials.gov NCT03679780 · fetched Nov 12, 2026
- Sex Differences in Myocardial Steatosis Induced Left Ventricular DysfunctionPHASE4 · UNKNOWN · started Sep 13, 2018ClinicalTrials.gov NCT04671966 · fetched Nov 12, 2026
- Pioglitazone to Reduce Sympathetic Overactivity in CKD PatientsPHASE4 · TERMINATED · started Apr 1, 2018ClinicalTrials.gov NCT03471117 · fetched Nov 12, 2026
- L-arginine to Reduce Sympathetic Nerve Activity in CKD PatientsPHASE4 · ACTIVE_NOT_RECRUITING · started Feb 1, 2018ClinicalTrials.gov NCT03982160 · fetched Nov 12, 2026